ADG20

· Invivyd, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ADG20, covering 2024-02-06 to 2024-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of ADG20 for the Prevention of COVID-19 [Phase 2, Phase 3]